Differential roles of prostaglandin E-type receptors in activation of hypoxia-inducible factor 1 by prostaglandin E1 in vascular-derived cells under non-hypoxic conditions

PeerJ

Volumn 2013, Issue 1, 2013, Pages

  Suzuki, Kengo ^a,b   Nishi, Kenichiro ^c   Takabuchi, Satoshi ^c   Kai, Shinichi ^a   Matsuyama, Tomonori ^a   Kurosawa, Shin ^b   Adachi, Takehiko ^d   Maruyama, Takayuki ^e   Fukuda, Kazuhiko ^a   Hirota, Kiichi ^c  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b TOHOKU UNIVERSITY HOSPITAL   (Japan)

^c KANSAI MEDICAL UNIVERSITY   (Japan)

^d Kitano Hospital   (Japan)

^e ONO PHARMACEUTICAL CO   (Japan)

Author keywords

Angiogenesis; EP receptor; Human endothelial cells; Human smooth muscle cells; Hypoxia inducible factor; Prostaglandin E1; VEGF

Indexed keywords

BETA ACTIN; HYPOXIA INDUCIBLE FACTOR 1; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E1; PROTEIN KINASE C; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; ELECTRIC RESISTANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SLOW MUSCLE FIBER; SPECTROPHOTOMETRY; UPREGULATION;

EID: 84891506888     PISSN: None     EISSN: 21678359     Source Type: Journal    
DOI: 10.7717/peerj.220     Document Type: Article

References (36)

1. Amano H, Hayashi I, Endo H, Kitasato H, Yamashina S, Maruyama T, Kobayashi M, Satoh K, Narita M, Sugimoto Y, Murata T, Yoshimura H, Narumiya S, Majima M. 2003. Host prostaglandin E(2)-EP3 signaling regulates tumor-associated angiogenesis and tumor growth. Journal of Experimental Medicine 197:221-232 DOI 10.1084/jem.20021408.
2. Andrade DR Jr, Andrade DR, Santos SA. 2009. Study of rat hepatocytes in primary culture submitted to hypoxia and reoxygenation: action of the cytoprotectors prostaglandin E1, superoxide dismutase, allopurinol and verapamil. Arquivos de Gastroenterologia 46:333-340 DOI 10.1590/S0004-28032009000400016.
3. Cattaneo MG, Pola S, Deho V, Sanguini AM, Vicentini LM. 2003. Alprostadil suppresses angiogenesis in vitro and in vivo in the murine Matrigel plug assay. British Journal of Pharmacology 138:377-385 DOI 10.1038/sj.bjp.0705051.
4. Cawello W, Leonhardt A, Schweer H, Seyberth HW, Bonn R, Lomeli AL. 1995. Dose proportional pharmacokinetics of alprostadil (prostaglandin E1) in healthy volunteers following intravenous infusion. British Journal of Clinical Pharmacology 40:273-276 DOI 10.1111/j.1365-2125.1995.tb05784.x.
5. Coleman RA, Smith WL, Narumiya S. 1994. International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacological Reviews 46:205-229.
6. Daijo H, Kai S, Tanaka T, Wakamatsu T, Kishimoto S, Suzuki K, Harada H, Takabuchi S, Adachi T, Fukuda K, Hirota K. 2011. Fentanyl activates hypoxia-inducible factor 1 in neuronal SH-SY5Y cells and mice under non-hypoxic conditions in a mu-opioid receptor-dependent manner. European Journal of Pharmacology 667:144-152 DOI 10.1016/j.ejphar.2011.06.014.
7. Dery MA, Michaud MD, Richard DE. 2005. Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators. International Journal of Biochemistry & Cell Biology 37:535-540 DOI 10.1016/j.biocel.2004.08.012.
8. Fukuda R, Hirota K, Fan F, Jung YD, Ellis LM, Semenza GL. 2002. Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. Journal of Biological Chemistry 277:38205-38211 DOI 10.1074/jbc. M203781200.
9. Fukuda R, Kelly B, Semenza GL. 2003. Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1. Cancer Research 63:2330-2334.
10. Gorlach A, Diebold I, Schini-Kerth VB, Berchner-Pfannschmidt U, Roth U, Brandes RP, Kietzmann T, Busse R. 2001. Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: role of the p22(phox)-containing NADPH oxidase. Circulation Research 89:47-54 DOI 10.1161/hh1301.092678.
11. Haider DG, Bucek RA, Giurgea AG, Maurer G, Glogar H, Minar E, Wolzt M, Mehrabi MR, Baghestanian M. 2005. PGE1 analog alprostadil induces VEGF and eNOS expression in endothelial cells. American Journal of Physiology - Heart and Circulatory Physiology 289:H2066-H2072 DOI 10.1152/ajpheart.00147.2005.
12. Han C, Michalopoulos GK, Wu T. 2006. Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells. Journal of Cellular Physiology 207:261-270 DOI 10.1002/jcp.20560.
13. Hirota K, Fukuda R, Takabuchi S, Kizaka-Kondoh S, Adachi T, Fukuda K, Semenza GL. 2004. Induction of hypoxia-inducible factor 1 activity by muscarinic acetylcholine receptor signaling. Journal of Biological Chemistry 279:41521-41528 DOI 10.1074/jbc. M405164200.
14. Hirota K, Semenza GL. 2005. Regulation of hypoxia-inducible factor 1 by prolyl and asparaginyl hydroxylases. Biochemical and Biophysical Research Communications 338:610-616 DOI 10.1016/j.bbrc.2005.08.193.
15. Hirota K, Semenza GL. 2006. Regulation of angiogenesis by hypoxia-inducible factor 1. Critical Reviews in Oncology/Hematology 59:15-26 DOI 10.1016/j.critrevonc.2005.12.003.
16. Inoue H, Aihara M, Tomioka M, Watabe Y. 2013. Specific enhancement of vascular endothelial growth factor (VEGF) production in ischemic region by alprostadil - potential therapeutic application in pharmaceutical regenerative medicine. Journal of Pharmacological Sciences 122:158-161 DOI 10.1254/jphs.13033SC.
17. Ji R, Chou CL, Xu W, Chen XB, Woodward DF, Regan JW. 2010. EP1 prostanoid receptor coupling to Gi=o up-regulates the expression of hypoxia-inducible factor-1α through activation of a phosphoinositide-3 kinase signaling pathway. Molecular Pharmacology 77:1025-1036 DOI 10.1124/mol.110.063933.
18. Kaneshiro T, Okumura M, Maalouf S, Uflacker A, Maruyama T, Kawamori T. 2009. Inhibition of prostaglandin E2 signaling through the EP1 receptor does not affect prostacyclin production in human endothelial cells. Prostaglandins & Other Lipid Mediators 90:31-36 DOI 10.1016/j.prostaglandins.2009.07.003.
19. Kasuno K, Takabuchi S, Fukuda K, Kizaka-Kondoh S, Yodoi J, Adachi T, Semenza GL, Hirota K. 2004. Nitric oxide induces hypoxia-inducible factor 1 activation that is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling. Journal of Biological Chemistry 279:2550-2558 DOI 10.1074/jbc. M308197200.
20. Kimura M, Takabuchi S, Tanaka T, Murata M, Nishi K, Oda S, Oda T, Kanai M, Fukuda K, Kizaka-Kondoh S, Adachi T, Takabayashi A, Semenza GL, Hirota K. 2008. n-Propyl gallate activates hypoxia-inducible factor 1 by modulating intracellular oxygen-sensing systems. Biochemical Journal 411:97-105 DOI 10.1042/BJ20070824.
21. Laughner E, Taghavi P, Chiles K, Mahon PC, Semenza GL. 2001. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1α (HIF-1α) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Molecular and Cellular Biology 21:3995-4004 DOI 10.1128/MCB.21.12.3995-4004.2001.
22. Mehrabi MR, Serbecic N, Tamaddon F, Pacher R, Horvath R, Mall G, Glogar HD. 2003. Clinical benefit of prostaglandin E1-treatment of patients with ischemic heart disease: stimulation of therapeutic angiogenesis in vital and infarcted myocardium. Biomedicine & Pharmacotherapy 57:173-178 DOI 10.1016/S0753-3322(03)00026-X.
23. Narumiya S, Sugimoto Y, Ushikubi F. 1999. Prostanoid receptors: structures, properties, and functions. Physiological Reviews 79:1193-1226.
24. Nizet V, Johnson RS. 2009. Interdependence of hypoxic and innate immune responses. Nature Reviews Immunology 9:609-617 DOI 10.1038/nri2607.
25. Oda S, Oda T, Nishi K, Takabuchi S, Wakamatsu T, Tanaka T, Adachi T, Fukuda K, Semenza GL, Hirota K. 2008. Macrophage migration inhibitory factor activates hypoxia-inducible factor in a p53-dependent manner. PLoS ONE 3:e2215 DOI 10.1371/journal.pone.0002215.
26. Oda S, Oda T, Takabuchi S, Nishi K, Wakamatsu T, Tanaka T, Adachi T, Fukuda K, Nohara R, Hirota K. 2009. The calcium channel blocker cilnidipine selectively suppresses hypoxia-inducible factor 1 activity in vascular cells. European Journal of Pharmacology 606:130-136 DOI 10.1016/j.ejphar.2009.01.012.
27. Oda T, Hirota K, Nishi K, Takabuchi S, Oda S, Yamada H, Arai T, Fukuda K, Kita T, Adachi T, Semenza GL, Nohara R. 2006. Activation of hypoxia-inducible factor 1 during macrophage differentiation. American Journal of Physiology - Cell Physiology 291:C104-C113 DOI 10.1152/ajpcell.00614.2005.
28. Pouyssegur J, Mechta-Grigoriou F. 2006. Redox regulation of the hypoxia-inducible factor. Biological Chemistry 387:1337-1346 DOI 10.1515/BC.2006.167.
29. Schofield CJ, Ratcliffe PJ. 2005. Signalling hypoxia by HIF hydroxylases. Biochemical and Biophysical Research Communications 338:617-626 DOI 10.1016/j.bbrc.2005.08.111.
30. Sugimoto Y, Narumiya S. 2007. Prostaglandin E receptors. Journal of Biological Chemistry 282:11613-11617 DOI 10.1074/jbc. R600038200.
31. Suzawa T, Miyaura C, Inada M, Maruyama T, Sugimoto Y, Ushikubi F, Ichikawa A, Narumiya S, Suda T. 2000. The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs. Endocrinology 141:1554-1559 DOI 10.1210/en.141.4.1554.
32. Takabuchi S, Hirota K, Nishi K, Oda S, Oda T, Shingu K, Takabayashi A, Adachi T, Semenza GL, Fukuda K. 2004. The intravenous anesthetic propofol inhibits hypoxia-inducible factor 1 activity in an oxygen tension-dependent manner. FEBS Letters 577:434-438 DOI 10.1016/j.febslet.2004.10.042.
33. Tanaka T, Kai S, Koyama T, Daijo H, Adachi T, Fukuda K, Hirota K. 2011. General anesthetics inhibit erythropoietin induction under hypoxic conditions in the mouse brain. PLoS ONE 6:e29378 DOI 10.1371/journal.pone.0029378.
34. Tanaka T, Wakamatsu T, Daijo H, Oda S, Kai S, Adachi T, Kizaka-Kondoh S, Fukuda K, Hirota K. 2010. Persisting mild hypothermia suppresses hypoxia-inducible factor-1alpha protein synthesis and hypoxia-inducible factor-1-mediated gene expression. American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 298:R661-R671 DOI 10.1152/ajpregu.00732.2009.
35. Wang GL, Jiang BH, Rue EA, Semenza GL. 1995. Hypoxia-inducible factor 1 is a basic-helix-loophelix- PAS heterodimer regulated by cellular O2 tension. Proceedings of the National Academy of Sciences of the United States of America 92:5510-5514 DOI 10.1073/pnas.92.12.5510.
36. Weiss TW, Mehrabi MR, Kaun C, Zorn G, Kastl SP, SpeidlWS, Pfaffenberger S, Rega G, Glogar HD, Maurer G, Pacher R, Huber K, Wojta J. 2004. Prostaglandin E1 induces vascular endothelial growth factor-1 in human adult cardiac myocytes but not in human adult cardiac fibroblasts via a cAMP-dependent mechanism. Journal of Molecular and Cellular Cardiology 36:539-546 DOI 10.1016/j.yjmcc.2004.02.001.